Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Transgene and ProBioGen Expand Strategic Partnership with Additional License Agreement for AGE1.CR.pIX Cell Line.
Sep 08, 2026
Contract Type
partnership
Bas-RhinBiotechnologyHealth CareTherapeutics
Description
Transgene and ProBioGen have broadened their strategic partnership through an additional license agreement for the AGE1.CR.pIX® cell line. This agreement enhances Transgene's manufacturing capabilities aimed at optimizing vaccine production and scalability.
Company Information
Company
Transgene
Location
Bas-Rhin, Grand Est, France
About
Transgene is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines and oncolytic viruses with the goal of indirectly or directly killing cancer cells.